Amid pressure from pro-life groups, the Department of Health and Human Services has terminated the Food and Drug Administration’s contract with Advanced Bioscience Resources for “fresh” human fetal tissue.
The contract with the California-based fetal supply organization, one of the oldest of its kind in the United States, was worth nearly $16,000. The contract was agreed upon on July 25 for the FDA to acquire “fresh” fetal tissue to transplant into “humanized mice” in order to “create chimeric animals that have a human immune system.”
“After a recent review of a contract between ABR, Inc. and the [FDA] to provide human fetal tissue to develop testing protocols, HHS was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements,” an HHS statement released Monday night explains. “As a result, that contract has been terminated, and HHS is now conducting an audit of all acquisitions involving human fetal tissue to ensure conformity with procurement and human fetal tissue research laws and regulations.”
In addition to terminating the contract, HHS also initiated a comprehensive review of all research involving fetal tissue to ensure they are following laws and regulations.
“Finally, HHS is continuing to review whether adequate alternatives exist to the use of human fetal tissue in HHS funded research and will ensure that efforts to develop such alternatives are funded and accelerated,” the HHS statement concluded.
Click here to read more.
Source: Christian Post